471 related articles for article (PubMed ID: 28238064)
21. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
[TBL] [Abstract][Full Text] [Related]
22. Detection and characterization of hepatocellular carcinoma in rats with liver cirrhosis: diagnostic value of combined use of MR positive and negative contrast agents.
Guo DM; Qiu TS; Bian J; Liu SF; Wang CZ
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):65-70. PubMed ID: 19208518
[TBL] [Abstract][Full Text] [Related]
23. Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats.
Zhang HL; Yu LX; Yang W; Tang L; Lin Y; Wu H; Zhai B; Tan YX; Shan L; Liu Q; Chen HY; Dai RY; Qiu BJ; He YQ; Wang C; Zheng LY; Li YQ; Wu FQ; Li Z; Yan HX; Wang HY
J Hepatol; 2012 Oct; 57(4):803-12. PubMed ID: 22727732
[TBL] [Abstract][Full Text] [Related]
24. Maresin-1 Prevents Liver Fibrosis by Targeting Nrf2 and NF-κB, Reducing Oxidative Stress and Inflammation.
Rodríguez MJ; Sabaj M; Tolosa G; Herrera Vielma F; Zúñiga MJ; González DR; Zúñiga-Hernández J
Cells; 2021 Dec; 10(12):. PubMed ID: 34943914
[TBL] [Abstract][Full Text] [Related]
25. Chronic Alcohol Consumption Promotes Diethylnitrosamine-Induced Hepatocarcinogenesis via Immune Disturbances.
Yan G; Wang X; Sun C; Zheng X; Wei H; Tian Z; Sun R
Sci Rep; 2017 May; 7(1):2567. PubMed ID: 28566719
[TBL] [Abstract][Full Text] [Related]
26. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
[TBL] [Abstract][Full Text] [Related]
27. In silico and in vivo hepatoprotective activity of the synthesized 5-benzylidene-2-thiohydantoin against diethylnitrosamine-induced liver injury in a rat model.
Akree LS; Amin ZA; Ahmad HO
Sci Rep; 2023 Mar; 13(1):4681. PubMed ID: 36949140
[TBL] [Abstract][Full Text] [Related]
28. Dietary supplementation of the citrus antioxidant auraptene inhibits N,N-diethylnitrosamine-induced rat hepatocarcinogenesis.
Sakata K; Hara A; Hirose Y; Yamada Y; Kuno T; Katayama M; Yoshida K; Zheng Q; Murakami A; Ohigashi H; Ikemoto K; Koshimizu K; Tanaka T; Mori H
Oncology; 2004; 66(3):244-52. PubMed ID: 15218316
[TBL] [Abstract][Full Text] [Related]
29. Chemoprevention by lipid-soluble tea polyphenols in diethylnitrosamine/phenobarbital-induced hepatic pre-cancerous lesions.
Shen T; Khor SC; Zhou F; Duan T; Xu YY; Zheng YF; Hsu S; DE Stefano J; Yang J; Xu LH; Zhu XQ
Anticancer Res; 2014 Feb; 34(2):683-93. PubMed ID: 24511000
[TBL] [Abstract][Full Text] [Related]
30. Dissection of DEN-induced platelet proteome changes reveals the progressively dys-regulated pathways indicative of hepatocarcinogenesis.
Leng T; Liu N; Dai Y; Yu Y; Zhang C; Du R; Chen X
J Proteome Res; 2010 Dec; 9(12):6207-19. PubMed ID: 20919743
[TBL] [Abstract][Full Text] [Related]
31. Chronic Administration of Diethylnitrosamine and 2-Acetylaminofluorene Induces Hepatocellular Carcinoma in Wistar Rats.
Sánchez-Meza J; Campos-Valdez M; Domínguez-Rosales JA; Godínez-Rubí JM; Rodríguez-Reyes SC; Martínez-López E; Zúñiga-González GM; Sánchez-Orozco LV
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176094
[TBL] [Abstract][Full Text] [Related]
32. Diethylnitrosamine (DEN) induces irreversible hepatocellular carcinogenesis through overexpression of G1/S-phase regulatory proteins in rat.
Park DH; Shin JW; Park SK; Seo JN; Li L; Jang JJ; Lee MJ
Toxicol Lett; 2009 Dec; 191(2-3):321-6. PubMed ID: 19822196
[TBL] [Abstract][Full Text] [Related]
33. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis.
Schiffer E; Housset C; Cacheux W; Wendum D; Desbois-Mouthon C; Rey C; Clergue F; Poupon R; Barbu V; Rosmorduc O
Hepatology; 2005 Feb; 41(2):307-14. PubMed ID: 15660382
[TBL] [Abstract][Full Text] [Related]
34. Protective Effects of Total Glucosides of Paeony on N-nitrosodiethylamine-induced Hepatocellular Carcinoma in Rats via Down-regulation of Regulatory B Cells.
Song SS; Yuan PF; Li PP; Wu HX; Ni WJ; Lu JT; Wei W
Immunol Invest; 2015; 44(6):521-35. PubMed ID: 26207789
[TBL] [Abstract][Full Text] [Related]
35. Acteoside-mediates chemoprevention of experimental liver carcinogenesis through STAT-3 regulated oxidative stress and apoptosis.
Peerzada KJ; Faridi AH; Sharma L; Bhardwaj SC; Satti NK; Shashi B; Tasduq SA
Environ Toxicol; 2016 Jul; 31(7):782-98. PubMed ID: 26990576
[TBL] [Abstract][Full Text] [Related]
36. A novel antihepatitis drug, bicyclol, prevents liver carcinogenesis in diethylnitrosamine-initiated and phenobarbital-promoted mice tumor model.
Sun H; Yu L; Wei H; Liu G
J Biomed Biotechnol; 2012; 2012():584728. PubMed ID: 22500097
[TBL] [Abstract][Full Text] [Related]
37. Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs.
Mitchell J; Tinkey PT; Avritscher R; Van Pelt C; Eskandari G; Konnath George S; Xiao L; Cressman E; Morris JS; Rashid A; Kaseb AO; Amin HM; Uthamanthil R
Oncology; 2016; 91(2):90-100. PubMed ID: 27305144
[TBL] [Abstract][Full Text] [Related]
38. Thiamin Regresses the Anticancer Efficacy of Methotrexate in the Amelioration of Diethyl Nitrosamine-Induced Hepatocellular Carcinoma in Wistar Strain Rats.
Saleem S; Kazmi I; Ahmad A; Abuzinadah MF; Samkari A; Alkrathy HM; Khan R
Nutr Cancer; 2020; 72(1):170-181. PubMed ID: 31088230
[No Abstract] [Full Text] [Related]
39. A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma.
Memon A; Pyao Y; Jung Y; Lee JI; Lee WK
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751728
[TBL] [Abstract][Full Text] [Related]
40. Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma.
Mittenbühler MJ; Sprenger HG; Gruber S; Wunderlich CM; Kern L; Brüning JC; Wunderlich FT
Mol Metab; 2018 Nov; 17():122-133. PubMed ID: 30224299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
